2022 annual financial data
Corbus Pharmaceuticals Holdings 2022 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -34,835,445 USD and net income was -55,833,193 USD.
Operating cash flow was -37,544,435 USD.
Get free Corbus Pharmaceuticals Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -34,835,445 USD
- Net income
- -55,833,193 USD
- Operating cash flow
- -37,544,435 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Corbus Pharmaceuticals Holdings financial years